Journal
CANCER BIOLOGY & THERAPY
Volume 7, Issue 2, Pages 174-179Publisher
LANDES BIOSCIENCE
DOI: 10.4161/cbt.7.2.5262
Keywords
CLL; signal transduction; BCR; PI3K; Akt; p53; MiRNA; PKR; Bcl2; Src
Categories
Ask authors/readers for more resources
B-cell chronic lymphocytic leukemia (CLL) is caused by the abnormal accumulation of non-functional B-cells in peripheral blood and bone marrow. However, the precise aetiology and mechanism of the disease are unclear. Recently, progress has been made in the identification of both the genetic deficiencies and environmental factors that may underlie CLL. This has provided some clues to the nature of the disease, but no definitive cures. Although treatment has increased remission time, at present the disease is not curable by conventional therapy. Further studies of the pathogenesis of CLL are needed, as are the development of suitable cell lines and animal models in which to study it. This review summarises the most recent progress in CLL with emphasis on molecular events and possible implications in therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available